LX2761
Catalog No. A20597
LX2761 is chemically stable and potent inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 in vitro with IC50s of 2.2 nM and 2.7nM for hSGLT1 and hSGLT2, but displays specific SGLT1 inhibition in the gastrointestinal (GI) tract.
Catalog Num | A20597 |
---|---|
M. Wt | 601.8 |
Formula | C32H47N3O6S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1610954-97-6 |
Synonyms | LX-2761, LX2761 |
SMILES | CC1=CC=C([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](SC)O2)C=C1CC3=CC=C(CCCC(NC(C(NCCN(C)C)=O)(C)C)=O)C=C3 |
LX2761 is chemically stable and potent inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 in vitro with IC50s of 2.2 nM and 2.7nM for hSGLT1 and hSGLT2, but displays specific SGLT1 inhibition in the gastrointestinal (GI) tract.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 16.62 mL | 83.08 mL | 166.17 mL |
0.5 mM | 3.32 mL | 16.62 mL | 33.23 mL |
1 mM | 1.66 mL | 8.31 mL | 16.62 mL |
5 mM | 0.33 mL | 1.66 mL | 3.32 mL |
*The above data is based on the productmolecular weight 601.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.